peony ive thought all along that the hpv partner is going to be tied in with the hsv results somehow, which would explain why we hadn't heard about the collaboration yet.
as happy as i am with the rising share price, and in preparing for the worst but hoping for the best, id say most of today was spec buying that will get sold into the announcement. if its a monster though, todays volume will be but a drop in the ocean.
Ann: HSV-2 Phase IIa Results Investor Webinar, page-99
-
- There are more pages in this discussion • 198 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.90 |
Change
-0.100(0.56%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.81 | $16.48K | 915 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.18 | 21 | 2 |
View Market Depth
| Last trade - 11.28am 08/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |